Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_assertion type Assertion NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_head.
- NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_assertion description "[These findings suggest that FLJ10540 may be critical regulator of disease progression in NPC, and the underlying mechanism may involve in the osteopontin/CD44 pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_provenance.
- NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_assertion evidence source_evidence_literature NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_provenance.
- NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_assertion SIO_000772 22591637 NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_provenance.
- NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_assertion wasDerivedFrom befree-20150227 NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_provenance.
- NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_assertion wasGeneratedBy ECO_0000203 NP916863.RAuucplgFCyY1Uvp6d36f8gc9xDvNDA2FSOEdRijk54Ec130_provenance.